Nexentis Technologies (NXTS)
Market Price (7/23/2026): $2.04 | Market Cap: $1.2 MilSector: Materials | Industry: Fertilizers & Agricultural Chemicals
Nexentis Technologies (NXTS)
Market Price (7/23/2026): $2.04Market Cap: $1.2 MilSector: MaterialsIndustry: Fertilizers & Agricultural Chemicals
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -454% | Weak multi-year price returns2Y Excs Rtn is -132%, 3Y Excs Rtn is -166% Meaningful short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 16% | Very low revenueRev LTMTotal Revenue or Sales, Last Twelve Months is -66,000 Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -7.0 Mil Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -53%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -78% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -749% High stock price volatilityVol 12M is 566% Key risksNXTS key risks include [1] severe financial distress and a high probability of bankruptcy, Show more. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -454% |
| Weak multi-year price returns2Y Excs Rtn is -132%, 3Y Excs Rtn is -166% |
| Meaningful short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 16% |
| Very low revenueRev LTMTotal Revenue or Sales, Last Twelve Months is -66,000 |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -7.0 Mil |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -53%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -78% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -749% |
| High stock price volatilityVol 12M is 566% |
| Key risksNXTS key risks include [1] severe financial distress and a high probability of bankruptcy, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Updated on 7/17/2026
Nexentis Technologies (NXTS) stock has lost about 55% since 3/31/2026 because of the following key factors:
1. Significant Losses and Going Concern Doubt in Fiscal Q1 2026.
Nexentis Technologies reported a substantial net loss of $6.6 million, or $10.74 per basic share, for fiscal Q1 2026, which ended on March 31, 2026. This was primarily driven by an $8.2 million operating loss and a $6.3 million non-cash goodwill impairment related to its MitoCareX oncology unit. Credit and solvency analysts highlighted "going concern doubt," emphasizing the heightened balance-sheet risk due to the company's loss-making core business. The company's cash runway is estimated at less than one year, with a free cash flow trend of -$3.9 million.
2. Shareholder Dilution and Subsequent Capital Raise.
Shareholders faced significant dilution, with shares outstanding increasing over fivefold in the past year, further impacted by a one-for-seven reverse stock split that became effective on April 8, 2026. Despite this, on June 22, 2026, Nexentis raised approximately $2.9 million through a registered direct offering of 410,998 common shares at $7.056 per share, accompanied by five-year warrants. This capital infusion, while providing short-term liquidity, introduces further potential future dilution.
Show more
Nexentis Technologies (NXTS) stock has lost about 55% since 3/31/2026 because of the following key factors:
1. Significant Losses and Going Concern Doubt in Fiscal Q1 2026.
Nexentis Technologies reported a substantial net loss of $6.6 million, or $10.74 per basic share, for fiscal Q1 2026, which ended on March 31, 2026. This was primarily driven by an $8.2 million operating loss and a $6.3 million non-cash goodwill impairment related to its MitoCareX oncology unit. Credit and solvency analysts highlighted "going concern doubt," emphasizing the heightened balance-sheet risk due to the company's loss-making core business. The company's cash runway is estimated at less than one year, with a free cash flow trend of -$3.9 million.
2. Shareholder Dilution and Subsequent Capital Raise.
Shareholders faced significant dilution, with shares outstanding increasing over fivefold in the past year, further impacted by a one-for-seven reverse stock split that became effective on April 8, 2026. Despite this, on June 22, 2026, Nexentis raised approximately $2.9 million through a registered direct offering of 410,998 common shares at $7.056 per share, accompanied by five-year warrants. This capital infusion, while providing short-term liquidity, introduces further potential future dilution.
Show more
Updated on 7/17/2026
Nexentis Technologies (NXTS) stock has lost about 55% since 3/31/2026 because of the following key factors:
1. Significant Losses and Going Concern Doubt in Fiscal Q1 2026.
Nexentis Technologies reported a substantial net loss of $6.6 million, or $10.74 per basic share, for fiscal Q1 2026, which ended on March 31, 2026. This was primarily driven by an $8.2 million operating loss and a $6.3 million non-cash goodwill impairment related to its MitoCareX oncology unit. Credit and solvency analysts highlighted "going concern doubt," emphasizing the heightened balance-sheet risk due to the company's loss-making core business. The company's cash runway is estimated at less than one year, with a free cash flow trend of -$3.9 million.
2. Shareholder Dilution and Subsequent Capital Raise.
Shareholders faced significant dilution, with shares outstanding increasing over fivefold in the past year, further impacted by a one-for-seven reverse stock split that became effective on April 8, 2026. Despite this, on June 22, 2026, Nexentis raised approximately $2.9 million through a registered direct offering of 410,998 common shares at $7.056 per share, accompanied by five-year warrants. This capital infusion, while providing short-term liquidity, introduces further potential future dilution.
3. Lack of Institutional Confidence and Stockholder Selling.
On July 13, 2026, a filing disclosed that certain stockholders plan to sell up to 2.57 million shares of common stock, with all proceeds directed to the selling stockholders and not to the company. This action suggests a potential "shift in sentiment" among existing investors and raises questions regarding the company's current financial health. Adding to this cautious outlook, the sole Wall Street analyst covering Nexentis Technologies has issued a "Sell" rating for the stock.
4. Extreme Volatility and Unsustainable Price Spikes.
The stock experienced extreme volatility, characterized by an average weekly change of 18% over the past three months. This included a dramatic surge of 259.45% on June 22, 2026, where the stock closed at $18.24 following the announcement of an AI drug discovery initiative. However, this speculative rally proved unsustainable, with the stock declining significantly to trade around $3.15 by July 15, 2026, demonstrating that temporary, news-driven spikes were not supported by fundamental improvements.
Show less
Nexentis Technologies (NXTS) stock has lost about 55% since 3/31/2026 because of the following key factors:
1. Significant Losses and Going Concern Doubt in Fiscal Q1 2026.
Nexentis Technologies reported a substantial net loss of $6.6 million, or $10.74 per basic share, for fiscal Q1 2026, which ended on March 31, 2026. This was primarily driven by an $8.2 million operating loss and a $6.3 million non-cash goodwill impairment related to its MitoCareX oncology unit. Credit and solvency analysts highlighted "going concern doubt," emphasizing the heightened balance-sheet risk due to the company's loss-making core business. The company's cash runway is estimated at less than one year, with a free cash flow trend of -$3.9 million.
2. Shareholder Dilution and Subsequent Capital Raise.
Shareholders faced significant dilution, with shares outstanding increasing over fivefold in the past year, further impacted by a one-for-seven reverse stock split that became effective on April 8, 2026. Despite this, on June 22, 2026, Nexentis raised approximately $2.9 million through a registered direct offering of 410,998 common shares at $7.056 per share, accompanied by five-year warrants. This capital infusion, while providing short-term liquidity, introduces further potential future dilution.
3. Lack of Institutional Confidence and Stockholder Selling.
On July 13, 2026, a filing disclosed that certain stockholders plan to sell up to 2.57 million shares of common stock, with all proceeds directed to the selling stockholders and not to the company. This action suggests a potential "shift in sentiment" among existing investors and raises questions regarding the company's current financial health. Adding to this cautious outlook, the sole Wall Street analyst covering Nexentis Technologies has issued a "Sell" rating for the stock.
4. Extreme Volatility and Unsustainable Price Spikes.
The stock experienced extreme volatility, characterized by an average weekly change of 18% over the past three months. This included a dramatic surge of 259.45% on June 22, 2026, where the stock closed at $18.24 following the announcement of an AI drug discovery initiative. However, this speculative rally proved unsustainable, with the stock declining significantly to trade around $3.15 by July 15, 2026, demonstrating that temporary, news-driven spikes were not supported by fundamental improvements.
Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →
Stock Movement Drivers
Fundamental Drivers
The -55.4% change in NXTS stock from 3/31/2026 to 7/22/2026 was primarily driven by a -35.3% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 3312026 | 7222026 | Change |
|---|---|---|---|
| Stock Price ($) | 4.62 | 2.06 | -55.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | -0 | -0 | 0.0% |
| P/S Multiple | -27.7 | -19.1 | -31.1% |
| Shares Outstanding (Mil) | 0 | 1 | -35.3% |
| Cumulative Contribution | -55.4% |
Market Drivers
3/31/2026 to 7/22/2026| Return | Correlation | |
|---|---|---|
| NXTS | -55.4% | |
| Market (SPY) | 14.9% | 30.4% |
| Sector (XLB) | 1.7% | 29.5% |
Fundamental Drivers
The -82.5% change in NXTS stock from 12/31/2025 to 7/22/2026 was primarily driven by a -78.0% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 12312025 | 7222026 | Change |
|---|---|---|---|
| Stock Price ($) | 11.76 | 2.06 | -82.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | -0 | -0 | -1.5% |
| P/S Multiple | -23.7 | -19.1 | -19.2% |
| Shares Outstanding (Mil) | 0 | 1 | -78.0% |
| Cumulative Contribution | -82.5% |
Market Drivers
12/31/2025 to 7/22/2026| Return | Correlation | |
|---|---|---|
| NXTS | -82.5% | |
| Market (SPY) | 9.9% | 25.4% |
| Sector (XLB) | 12.6% | 21.7% |
Fundamental Drivers
The -96.3% change in NXTS stock from 6/30/2025 to 7/22/2026 was primarily driven by a -89.2% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 6302025 | 7222026 | Change |
|---|---|---|---|
| Stock Price ($) | 56.35 | 2.06 | -96.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | -0 | -0 | 53.5% |
| P/S Multiple | -86.8 | -19.1 | -78.0% |
| Shares Outstanding (Mil) | 0 | 1 | -89.2% |
| Cumulative Contribution | -96.3% |
Market Drivers
6/30/2025 to 7/22/2026| Return | Correlation | |
|---|---|---|
| NXTS | -96.3% | |
| Market (SPY) | 22.0% | 21.1% |
| Sector (XLB) | 17.4% | 18.3% |
Fundamental Drivers
The -99.8% change in NXTS stock from 6/30/2023 to 7/22/2026 was primarily driven by a -383.6% change in the company's P/S Multiple.| (LTM values as of) | 6302023 | 7222026 | Change |
|---|---|---|---|
| Stock Price ($) | 1014.42 | 2.06 | -99.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 0 | -0 | -115.4% |
| P/S Multiple | 6.7 | -19.1 | -383.6% |
| Shares Outstanding (Mil) | 0 | 1 | -99.5% |
| Cumulative Contribution | -99.8% |
Market Drivers
6/30/2023 to 7/22/2026| Return | Correlation | |
|---|---|---|
| NXTS | -99.8% | |
| Market (SPY) | 74.6% | 10.6% |
| Sector (XLB) | 29.4% | 8.2% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| NXTS Return | -53% | -81% | -62% | -88% | -81% | -82% | -100% |
| Peers Return | 27% | -32% | 69% | 25% | -7% | -31% | 17% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 10% | 100% |
Monthly Win Rates [3] | |||||||
| NXTS Win Rate | 33% | 33% | 33% | 17% | 25% | 29% | |
| Peers Win Rate | 62% | 28% | 63% | 58% | 38% | 37% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 57% | |
Max Drawdowns [4] | |||||||
| NXTS Max Drawdown | -86% | -90% | -84% | -92% | -98% | -95% | |
| Peers Max Drawdown | -18% | -43% | -17% | -23% | -35% | -42% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: MSFT, ORCL, CRM, ADBE, NOW.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 7/22/2026 (YTD)
How Low Can It Go
| Event | NXTS | S&P 500 |
|---|---|---|
| 2024 Yen Carry Trade Unwind | ||
| % Loss | -36.9% | -7.8% |
| % Gain to Breakeven | 58.4% | 8.5% |
| Time to Breakeven | 140 days | 18 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -52.3% | -6.7% |
| % Gain to Breakeven | 109.6% | 7.1% |
| Time to Breakeven | 42 days | 31 days |
| 2020 COVID-19 Crash | ||
| % Loss | -17.6% | -33.7% |
| % Gain to Breakeven | 21.4% | 50.9% |
| Time to Breakeven | 5 days | 140 days |
In The Past
Nexentis Technologies's stock fell -36.9% during the 2024 Yen Carry Trade Unwind. Such a loss loss requires a 58.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | NXTS | S&P 500 |
|---|---|---|
| 2024 Yen Carry Trade Unwind | ||
| % Loss | -36.9% | -7.8% |
| % Gain to Breakeven | 58.4% | 8.5% |
| Time to Breakeven | 140 days | 18 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -52.3% | -6.7% |
| % Gain to Breakeven | 109.6% | 7.1% |
| Time to Breakeven | 42 days | 31 days |
In The Past
Nexentis Technologies's stock fell -36.9% during the 2024 Yen Carry Trade Unwind. Such a loss loss requires a 58.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Nexentis Technologies (NXTS)
N2OFF, Inc., an agri-food tech company, engages in the development and sale of eco-friendly green solutions for the food industry to enhance food safety and shelf life of fresh produce. Its products are based on proprietary blend of food acids combined with various oxidizing agent-based sanitizers and low concentrated fungicides for cleaning, sanitizing, and controlling pathogens on fresh produce that are safer for human consumption and extend their shelf life by reducing their decay. The company's products include SavePROTECT or PeroStar, a processing aid for post-harvest application that is added to fruit and vegetable wash water; and SF3HS and SF3H, a post-harvest cleaning and sanitizing solution to control plant and foodborne pathogens. It also offers SpuDefender for controlling post-harvest potato sprouts; and FreshProtect to control spoilage-creating microorganisms on post-harvest citrus fruit. The company was formerly known as Save Foods, Inc. and changed its name to N2OFF, Inc. in March 2024. N2OFF, Inc. was incorporated in 2009 and is headquartered in Hod HaSharon, Israel.
AI Analysis | Feedback
null
AI Analysis | Feedback
- SavePROTECT or PeroStar: A processing aid applied post-harvest to fruit and vegetable wash water to enhance food safety and shelf life.
- SF3HS and SF3H: Post-harvest cleaning and sanitizing solutions designed to control plant and foodborne pathogens on fresh produce.
- SpuDefender: A specialized product formulated to control post-harvest potato sprouts, preventing premature sprouting.
- FreshProtect: A solution developed to control spoilage-creating microorganisms specifically on post-harvest citrus fruit.
AI Analysis | Feedback
Nexentis Technologies (symbol: NXTS), which operates as N2OFF, Inc., sells primarily to other companies (Business-to-Business or B2B).
Here are the categories of its major customers:
- Fresh Produce Packers & Processors: These companies are involved in the post-harvest washing, sanitizing, and packaging of fruits and vegetables before distribution to retailers or consumers. They utilize N2OFF's solutions to enhance food safety and extend shelf life.
- Agricultural Distributors & Wholesalers: Entities that handle large volumes of fresh produce, often storing and preparing it for further distribution. They leverage N2OFF's products to maintain the quality and reduce decay of produce during storage and transit.
- Large-Scale Commercial Farms/Growers: Especially those that integrate post-harvest treatment and processing operations into their farming practices. They use N2OFF's specialized solutions for specific crops like potatoes (SpuDefender) and citrus fruits (FreshProtect) to control sprouts and spoilage.
AI Analysis | Feedback
null
AI Analysis | Feedback
Nexentis Technologies Inc. (NXTS) has a management team that includes experienced professionals in leadership, finance, and business development. The company, formerly known as N2OFF, Inc., recently rebranded in February 2026 and pivoted its focus to computational biotech, while maintaining non-core solar energy investments.
Here is an overview of key management team members:
David Palach – Chief Executive Officer
David Palach was appointed Co-Chief Executive Officer of Save Foods (the predecessor to N2OFF, Inc., and now Nexentis Technologies Inc.) on November 5, 2020, and later became the sole CEO. He brings extensive experience in business development and financial management. [cite: 4 - prior search] Palach previously spent over a decade at Intel Israel, where he held the position of Manager of Business Development for Israel and Europe, and served as a controller for two of Intel's largest factories, overseeing a budget exceeding $1 billion. He is also the owner of ST Sporting Ltd. and Sunlight Green Lighting Solutions Ltd., companies specializing in environmental packaging, logistics, and business consulting. Additionally, he served as CEO of B-Pure Corporation Ltd., an environmental management and maintenance company, where he successfully turned around several struggling subsidiaries.
Lital Barda – Chief Financial Officer and Principal Accounting Officer
Lital Barda serves as the Chief Financial Officer and Principal Accounting Officer for Nexentis Technologies Inc. (formerly N2OFF, Inc.). [cite: 1 - prior search] In this role, she is responsible for overseeing the company's financial operations, ensuring fiscal responsibility, and contributing to strategic financial planning to support the company's growth. [cite: 4 - prior search]
Amitay Weiss – Chairman of the Board
Amitay Weiss provides strategic oversight and leadership as the Active Chairman of the Board for Nexentis Technologies Inc. [cite: 1 - prior search, 6]
Yaki Baranes – Head of Business Development
Yaki Baranes is the Head of Business Development. He leverages over 16 years of experience in business strategy, specializing in corporate and business unit-level planning and implementation, and has assisted start-up companies in refining business plans and raising capital. [cite: 4 - prior search]
Galit Kenigsberg – Head of Sustainable Activity
Galit Kenigsberg is the Head of Sustainable Activity. She drives the company's efforts to promote environmentally responsible practices across its operations, aligning with sustainability goals and regulatory standards. [cite: 4 - prior search]
AI Analysis | Feedback
The key risks to Nexentis Technologies (NXTS), an agri-food tech company focused on enhancing food safety and shelf life of fresh produce, include:
- Regulatory Approval and Compliance Risk: Nexentis Technologies develops and sells products based on a proprietary blend of food acids, oxidizing agent-based sanitizers, and low concentrated fungicides for use on fresh produce. These types of products, intended for human consumption, are subject to stringent regulations by food safety authorities in various jurisdictions. The company faces significant risks related to obtaining and maintaining the necessary regulatory approvals for its products in target markets, which can be a complex, costly, and time-consuming process. Any changes in food safety regulations, stricter interpretations of existing rules, or difficulties in demonstrating ongoing compliance could severely limit the company's ability to manufacture, market, and sell its solutions. Additionally, public perception regarding the use of "fungicides" on fresh produce, even in low concentrations and with eco-friendly claims, could lead to increased regulatory scrutiny or consumer reluctance.
- Market Acceptance and Intense Competition: The market for post-harvest food safety and shelf-life extension solutions is highly competitive, featuring both established chemical treatments and a growing number of alternative "green" or organic solutions. Nexentis Technologies' success hinges on its ability to differentiate its eco-friendly green solutions and gain widespread market acceptance among growers, distributors, and retailers. This requires demonstrating superior efficacy, cost-effectiveness, ease of application, and clear benefits over existing methods or competing technologies. Failure to effectively penetrate the market, overcome resistance to new technologies, or compete on price and performance could significantly impede revenue growth and profitability.
- Intellectual Property Protection and Efficacy Risk: The company's products are based on a "proprietary blend" of ingredients. Protecting this intellectual property through patents, trade secrets, and other legal means is crucial for maintaining a competitive advantage. Risks include the potential for competitors to develop similar or superior formulations, challenges to the validity or scope of existing patents, or the expiration of key patents, which could lead to increased competition and erode market share. Furthermore, the long-term success of the business depends on the consistent and scientifically proven efficacy of its products in real-world agricultural and food processing environments. Any credible reports or scientific findings that question the effectiveness or long-term safety of their solutions could severely damage the company's reputation, lead to product recalls, and negatively impact sales.
AI Analysis | Feedback
null
AI Analysis | Feedback
The addressable markets for Nexentis Technologies' (symbol: NXTS) main products and services, as described in the background, primarily fall within the global post-harvest treatment and food safety markets for fresh produce.
The global market for post-harvest treatment of fruits and vegetables was valued at USD 12.60 billion in 2024 and is projected to reach USD 21.32 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period. This market includes solutions such as cleaners, sanitizers, fungicides, coatings, ethylene blockers, and sprout inhibitors. Nexentis Technologies' products, like SavePROTECT/PeroStar, SF3HS and SF3H, SpuDefender, and FreshProtect, are designed for post-harvest application to enhance food safety, extend shelf life, control pathogens, and inhibit sprouting on fresh produce, fitting directly into this global market.
Additionally, Nexentis Technologies' focus on enhancing food safety for fresh produce addresses a segment of the broader global food safety products market. This market was valued at USD 81.49 billion in 2024 and is anticipated to grow to USD 130.61 billion by 2035, exhibiting a CAGR of 4.38%. The company's solutions contribute to reducing foodborne pathogens and improving the safety of human consumption.
AI Analysis | Feedback
Nexentis Technologies, trading under the symbol NXTS, has historically operated as an agri-food tech company, N2OFF, Inc. (formerly Save Foods, Inc.). This entity focused on developing and selling eco-friendly green solutions to enhance food safety and extend the shelf life of fresh produce. Based on the business model described in the background, several key drivers are expected to contribute to its future revenue growth over the next 2-3 years:
Revenue Growth Drivers for Nexentis Technologies (NXTS) - Agri-Food Tech Focus:
- Expansion of Customer Base and Distribution Network: N2OFF, Inc. aimed to significantly grow its market presence by adding "100 new distributors by 2026" and leveraging existing partnerships, such as with Sun Pacific. This strategy targets increased adoption of its post-harvest solutions by more clients, including supermarkets and growers, across the U.S., Europe, and other regions.
- Increased Adoption of Eco-Friendly Post-Harvest Solutions: The growing consumer awareness regarding health and environmental concerns is driving demand for clean-label products and reduced food waste. N2OFF's products, including SavePROTECT/PeroStar, SF3HS/SF3H, SpuDefender, and FreshProtect, are designed to reduce food spoilage and minimize foodborne pathogens without harmful residues. The demonstrated efficacy, such as an average 50% reduction in spoiled fruit at retail, supports the potential for increased sales of these existing solutions.
- Innovation through Research and Development: The company had a stated goal to "invest more than $5 million in R&D by 2024" to translate "innovation into revenue". This commitment suggests the development and introduction of new or improved eco-friendly green solutions for enhancing food safety and shelf life, which would open new revenue streams.
- Addressing Global Food Waste and Safety Concerns: N2OFF, Inc.'s ambitious targets to "reduce food waste by over 30% by 2025" and "achieve a 50% reduction in foodborne illnesses associated with treated products by 2030" align with global sustainability trends and regulatory pushes. By offering solutions that address these critical issues, the company is poised to benefit from increased demand in the expanding market for sustainable agricultural practices and food security.
AI Analysis | Feedback
Share Issuance
- In a public offering, Save Foods, Inc. (now Nexentis Technologies Inc.) closed on the sale of 1,600,000 shares of common stock at $3.00 per share, raising gross proceeds of $4.8 million. The proceeds were intended for working capital and general corporate purposes.
- In February 2024, stockholders approved the issuance of 20% or more of the company's common stock under a Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd., which was initially entered into in December 2023.
- In May 2025, N2OFF (now Nexentis Technologies Inc.) secured a $3 million financing commitment through the SEPA and issued 675,675 Commitment Shares to the investor, valued at $300,000.
Inbound Investments
- N2OFF (now Nexentis Technologies Inc.) acquired MitoCareX Bio Ltd., a biotechnology company focused on drug discovery for cancer therapeutics.
Outbound Investments
- N2OFF (now Nexentis Technologies Inc.) has been investing in solar energy projects across various European Union countries.
- In July 2025, the company completed a $2.7 million investment in battery energy storage projects in Sicily, aiming for a $13.5 million valuation.
- N2OFF plans to invest an additional €25,000 in Germany.
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 144.42 |
| Mkt Cap | 120.1 |
| Rev LTM | 34,014 |
| Op Inc LTM | 9,228 |
| FCF LTM | 7,452 |
| FCF 3Y Avg | 6,248 |
| CFO LTM | 12,851 |
| CFO 3Y Avg | 11,202 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 14.4% |
| Rev Chg 3Y Avg | 10.8% |
| Rev Chg Q | 18.3% |
| QoQ Delta Rev Chg LTM | 3.7% |
| Op Inc Chg LTM | 20.1% |
| Op Inc Chg 3Y Avg | 19.2% |
| Op Mgn LTM | 33.3% |
| Op Mgn 3Y Avg | 31.7% |
| QoQ Delta Op Mgn LTM | 0.1% |
| CFO/Rev LTM | 41.6% |
| CFO/Rev 3Y Avg | 39.7% |
| FCF/Rev LTM | 33.1% |
| FCF/Rev 3Y Avg | 32.7% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Biotechnology activity | 0 | ||||
| Renewable energy projects | 0 | ||||
| Nitrous oxide (N2O) emissions Global warming solutions | 0 | 0 | |||
| Pathogen prevention and prolong shelf life | 0 | 0 | |||
| Single Segment | 0 | 0 | |||
| Total | 0 | 0 | 0 | 0 | 0 |
| $ Mil | 2025 | 2024 | 2023 |
|---|---|---|---|
| Change in fair value of contingent consideration | 1 | ||
| Depreciation | -0 | -0 | |
| Biotechnology activity | -0 | ||
| Renewable energy projects | -0 | ||
| Other general and administrative expenses | -1 | -0 | |
| Professional services | -2 | -2 | |
| Share base compensation | -2 | -1 | |
| Nitrous oxide (N2O) emissions Global warming solutions | -0 | -2 | |
| Pathogen prevention and prolong shelf life | -1 | -1 | |
| Unallocated costs | -5 | ||
| Total | -4 | -4 | -8 |
Price Behavior
Price Behavior
| Market Price | $2.06 | |
| Market Cap ($ Bil) | 0.0 | |
| First Trading Date | 11/12/2010 | |
| Distance from 52W High | -97.5% | |
| 50 Days | 200 Days | |
| DMA Price | $4.61 | $11.00 |
| DMA Trend | down | up |
| Distance from DMA | -55.3% | -81.3% |
| 3M | 1YR | |
| Volatility | 359.5% | 567.0% |
| Downside Capture | 96.22 | 357.20 |
| Upside Capture | -288.77 | -116.72 |
| Correlation (SPY) | 2.3% | 21.3% |
NXTS Betas & Captures as of 6/30/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.90 | 0.67 | 21.95 | 14.58 | 9.60 | 2.90 |
| Up Beta | 5.90 | 3.49 | 59.84 | 49.19 | 34.09 | 5.72 |
| Down Beta | 20.11 | 13.05 | 10.27 | 4.60 | 2.94 | 2.88 |
| Up Capture | -315% | -115% | -58% | 9% | -32% | -5% |
| Bmk +ve Days | 11 | 24 | 40 | 67 | 140 | 429 |
| Stock +ve Days | 8 | 17 | 25 | 45 | 96 | 293 |
| Down Capture | -69% | -114% | -188% | 213% | 182% | 111% |
| Bmk -ve Days | 10 | 17 | 23 | 58 | 112 | 321 |
| Stock -ve Days | 13 | 24 | 38 | 77 | 152 | 441 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with NXTS | |
|---|---|---|---|---|
| NXTS | -96.8% | 565.9% | 0.45 | - |
| Sector ETF (XLB) | 13.8% | 17.6% | 0.58 | 18.5% |
| Equity (SPY) | 20.0% | 12.6% | 1.16 | 21.2% |
| Gold (GLD) | 21.2% | 28.1% | 0.67 | 3.3% |
| Commodities (DBC) | 33.0% | 19.1% | 1.36 | -14.9% |
| Real Estate (VNQ) | 13.9% | 14.0% | 0.70 | 14.0% |
| Bitcoin (BTCUSD) | -43.6% | 42.9% | -1.21 | 3.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with NXTS | |
|---|---|---|---|---|
| NXTS | -82.9% | 332.5% | 0.20 | - |
| Sector ETF (XLB) | 6.3% | 19.0% | 0.22 | 7.6% |
| Equity (SPY) | 12.8% | 17.1% | 0.58 | 8.4% |
| Gold (GLD) | 17.3% | 18.4% | 0.76 | 4.8% |
| Commodities (DBC) | 9.3% | 19.5% | 0.37 | -3.4% |
| Real Estate (VNQ) | 2.7% | 18.9% | 0.04 | 6.3% |
| Bitcoin (BTCUSD) | 15.2% | 53.5% | 0.46 | 2.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with NXTS | |
|---|---|---|---|---|
| NXTS | -55.1% | 338.9% | 0.37 | - |
| Sector ETF (XLB) | 9.9% | 20.6% | 0.43 | 8.2% |
| Equity (SPY) | 15.1% | 17.9% | 0.72 | 8.6% |
| Gold (GLD) | 11.5% | 16.1% | 0.58 | 3.7% |
| Commodities (DBC) | 7.1% | 17.9% | 0.31 | -3.4% |
| Real Estate (VNQ) | 5.0% | 20.7% | 0.20 | 6.6% |
| Bitcoin (BTCUSD) | 58.5% | 66.2% | 0.99 | 2.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Updated 6/2/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/14/2026 | 10-Q |
| 12/31/2025 | 03/31/2026 | 10-K |
| 09/30/2025 | 11/13/2025 | 10-Q |
| 06/30/2025 | 08/14/2025 | 10-Q |
| 03/31/2025 | 05/15/2025 | 10-Q |
| 12/31/2024 | 03/31/2025 | 10-K |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 08/14/2024 | 10-Q |
| 03/31/2024 | 05/15/2024 | 10-Q |
| 12/31/2023 | 04/01/2024 | 10-K |
| 09/30/2023 | 11/14/2023 | 10-Q |
| 06/30/2023 | 08/14/2023 | 10-Q |
| 03/31/2023 | 05/15/2023 | 10-Q |
| 12/31/2022 | 03/27/2023 | 10-K |
| 09/30/2022 | 11/14/2022 | 10-Q |
| 06/30/2022 | 08/15/2022 | 10-Q |
| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/14/2026 | 10-Q |
| 12/31/2025 | 03/31/2026 | 10-K |
| 09/30/2025 | 11/13/2025 | 10-Q |
| 06/30/2025 | 08/14/2025 | 10-Q |
| 03/31/2025 | 05/15/2025 | 10-Q |
| 12/31/2024 | 03/31/2025 | 10-K |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 08/14/2024 | 10-Q |
| 03/31/2024 | 05/15/2024 | 10-Q |
| 12/31/2023 | 04/01/2024 | 10-K |
| 09/30/2023 | 11/14/2023 | 10-Q |
| 06/30/2023 | 08/14/2023 | 10-Q |
| 03/31/2023 | 05/15/2023 | 10-Q |
| 12/31/2022 | 03/27/2023 | 10-K |
| 09/30/2022 | 11/14/2022 | 10-Q |
| 06/30/2022 | 08/15/2022 | 10-Q |
| 03/31/2022 | 05/16/2022 | 10-Q |
| 12/31/2021 | 03/31/2022 | 10-K |
| 09/30/2021 | 11/15/2021 | 10-Q |
| 06/30/2021 | 08/16/2021 | 10-Q |
| 03/31/2021 | 05/18/2021 | 10-Q |
| 12/31/2020 | 03/29/2021 | 10-K |
| 09/30/2020 | 11/12/2020 | 10-Q |
| 06/30/2020 | 08/11/2020 | 10-Q |
| 03/31/2020 | 05/15/2020 | 10-Q |
| 12/31/2019 | 03/30/2020 | 10-K |
| 03/31/2014 | 05/20/2014 | 10-Q |
| 12/31/2013 | 03/10/2014 | 10-K |
Insider Activity
Updated 4/26/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Lee, Eun Young | Direct | Sell | 3262026 | 1.35 | 127 | 172 | 649,755 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Lee, Eun Young | Direct | Sell | 3262026 | 1.35 | 127 | 172 | 649,755 | Form |
Industry Resources
| Materials Resources |
| Chemical & Engineering News (C&EN) |
| Mining.com |
| Plastics News |
| Fertilizers & Agricultural Chemicals Resources |
| World Fertilizer |
| Fertilizer Daily |
| Argus Media - Fertilizer |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.
Core Cache Last Updated: 7/22/2026